Cumberland Pharmaceuticals (CPIX) Profit After Tax Growth (3y) (2013 - 2026)
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.87 Bn | 624.11 Bn | 17.26 Bn | 0.97% |
| 2 | AbbVie | 440.91 Bn | 434.35 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 366.10 Bn | 358.96 Bn | 12.21 Bn | 39.29% |
| 4 | Novartis Ag | 267.00 Bn | 259.31 Bn | 11.24 Bn | 12.02% |
| 5 | Pfizer | 159.23 Bn | 147.53 Bn | 10.94 Bn | -28.18% |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | -34.73% |
| 7 | Revolution Medicines | 44.24 Bn | 44.24 Bn | - | - |
| 8 | Incyte | 25.34 Bn | 20.80 Bn | 1.57 Bn | 42.23% |
| 9 | United Therapeutics | 21.48 Bn | 18.82 Bn | 683.80 Mn | 8.71% |
| 10 | Cumberland Pharmaceuticals | 94.76 Mn | 90.90 Mn | - | -90.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -90.41% |
| Mar 31, 2026 | -167.32% |
| Dec 31, 2025 | 16.57% |
| Sep 30, 2025 | -66.37% |
| Jun 30, 2025 | -30.00% |
| Mar 31, 2025 | 42.44% |
| Dec 31, 2024 | 24.29% |
| Sep 30, 2024 | 0.84% |
| Jun 30, 2024 | -42.56% |
| Mar 31, 2024 | -77.04% |
| Dec 31, 2023 | -52.20% |
| Sep 30, 2023 | 5.89% |
| Jun 30, 2023 | 36.07% |
| Mar 31, 2023 | 28.10% |
| Dec 31, 2022 | 9.96% |
| Sep 30, 2022 | 49.65% |
| Jun 30, 2022 | -0.65% |
| Mar 31, 2022 | -5.70% |
| Dec 31, 2021 | -25.49% |
| Sep 30, 2021 | 1.22% |